Search

Neuroprotection after cardiac arrest with 2-iminobiotin

Therapeutic area :

Admiraal M.M., Velseboer D.C., Tjabbes H., Vis P., Peeters-Scholte C., Horn J.

Neuroprotection after cardiac arrest with 2-iminobiotin: a single center phase IIa study on safety, tolerability, and pharmacokinetics. Frontiers in Neurology 2023. [Link to publication ].

Our expertise

Anti-infectives and immunology General modelling Blood disorders CNS Gastrointestinal Diseases Endocrinology/Sexual health Cardiovascular Oncology Biologicals Paediatrics Anesthesiology Methods Peripheral Nervous System Pain Diabetes Lung Diseases Safety pharmacology